Many patients begin to notice a drop in their appetite within the very first few weeks
These 3 studies blunted the argument to universally intensify glycemic control in all patients: rather, they highlighted the need for individualized glycemic targets
[10] [6] Clinical trials show that nausea occurs in approximately 1222% of patients with type 2 diabetes, while rates are higher in obesity treatmentoften in the mid-20s to low-30s percentage range, depending on dose
Statements Author contributions CB: Conceptualization, Investigation, Methodology, Writing original draft
We're physician-owned, physician-led, and we don't rush these decisions
How long does it take to receive my medication